Pharming Group N.V. (ADR)

General ticker "PHAR" information:

  • Sector: Health Care
  • Industry: Biotechnology
  • Capitalization: $1.0B (TTM average)

Pharming Group N.V. (ADR) does not follow the US Stock Market performance with the rate: -21.7%.

Estimated limits based on current volatility of 1.4%: low 11.26$, high 11.57$

Factors to consider:

  • Total employees count: 229 as of 2020
  • Earnings for 6 months up through Q2 are below our estimates

Stock Forecast*

* forecast is subjective and experimental, should not be used for any investment decisions

Long term estimates were made for the period from 2025-12-31 to 2027-12-31

  • 2025-12-31 to 2026-12-31 estimated range: [11.46$, 20.06$]
  • 2026-12-31 to 2027-12-31 estimated range: [10.44$, 18.69$]

Financial Metrics affecting the PHAR estimates:

  • Positive: with PPE of 1746.4 at the end of fiscal year the price was neutral
  • Positive: 2.37 < Operating cash flow per share per price, % of 4.39
  • Positive: 4.60 < Operating profit margin, % of 5.55
  • Positive: -0.55 < Return on assets ratio (scaled to [-100,100]) of 0.57
  • Positive: 49.86 < Shareholder equity ratio, % of 55.42 <= 58.56
  • Negative: -3.92 < Inventory ratio change, % of -1.55
  • Negative: negative Industry operating income (median)
  • Negative: negative Industry operating cash flow (median)
  • Positive: Industry inventory ratio change (median), % of 0 <= 0

Similar symbols

Short-term PHAR quotes

Long-term PHAR plot with estimates

Financial data

YTD 2024-12-31 2025-12-31
Operating Revenue $297.20MM $376.13MM
Operating Expenses $300.87MM $355.25MM
Operating Income $-3.67MM $20.88MM
Non-Operating Income $-4.83MM $-8.03MM
Interest Expense $9.05MM $10.72MM
R&D Expense $83.15MM $100.37MM
Income(Loss) $-8.49MM $12.85MM
Taxes $0.00MM $10.31MM
Net Income(Loss)* $-11.84MM $2.85MM
Stockholders Equity $228.91MM $277.02MM
Inventory $57.70MM $64.88MM
Assets $414.18MM $499.81MM
Operating Cash Flow $-1.79MM $54.71MM
Capital expenditure $0.80MM $0.76MM
Investing Cash Flow $31.62MM $26.25MM
Financing Cash Flow $-34.41MM $1.50MM
Earnings Per Share** $-0.17 $0.04
Ordinary share to ADR 1.00x 1.00x

* Profit(Loss) attributable to entity.
** EPS are Split Adjusted, recent splits may be reflected with a delay.